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Pathogenesis of cerebral edema after treatment of diabetic
ketoacidosis
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Pathogenesis of cerebral edema after treatment of diabetic ketoacido-
sis. We studied the roles of acidosis, plasma osmolality, and organic
osmolytes in the pathogenesis of cerebral edema in an animal model of
diabetes mellitus. Normonatremic rats with streptozotocin-induced non-
ketotic (NKD) and ketotic (DKA) diabetes were sacrificed before or after
treatment with hypotonic saline and insulin. Brains were analyzed for
water, electrolyte, and organic osmolyte content. Brain water decreased by
2% in untreated DKA and NKD despite a 12% increase in plasma
osmolality due to hyperglycemia. After treatment of both NKD and DKA,
brain water increased equivalently by 8%. The cerebral edema that
occurred after treatment was associated with decreased brain sodium
content and no change in total major brain organic osmolytes in both
NKD and DKA. However, brain content of the individual osmolytes
glutamine and taurine increased after treatment of DKA. In a separate
study, brain water and solute content of rats with DKA were compared
after treatment with either hypotonic or isotonic fluid. Animals treated
with isotonic fluid had significantly less cerebral edema and higher brain
sodium content than those treated with hypotonic fluid. In our studies,
brain swelling after treatment of DKA and NKD was primarily due to a
rapid reduction of plasma glucose and osmolality, and was not caused by
sodium movement into the brain. Acidosis did not appear to play a major
role in the pathogenesis of cerebral edema after treatment of DKA.
Cerebral edema after treatment of diabetic ketoacidosis (DKA)
is an important cause of death in children with insulin-dependent
diabetes mellitus [1—3]. Clinical studies have implicated a variety
of factors that predispose to cerebral edema, including degree of
acidosis and hyperglycemia, changes in plasma osmolality or
oncotic pressure, and hyponatremia [4—7]. The relative contribu-
tion of these factors to the pathogenesis of brain swelling remains
unclear. There is also disagreement over whether use of hypotonic
replacement fluid in the treatment of DKA predisposes to cere-
bral edema [8, 9].
Cerebral edema has rarely been reported during treatment of
the hyperosmolar nonketotic state in adults with noninsulin-
dependent diabetes mellitus [10—12]. To explain why brain swell-
ing is primarily a complication of ketoacidosis, van der Meulen,
Klip and Grinstein proposed that correction of acidosis in DKA
could predispose to cerebral edema by stimulation of the brain
Na/H+ exchanger [13]. They suggest that acidification of the
cytosol by organic ketoacids activates the plasma membrane
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NatTH+ exchanger, increasing brain sodium and water. Relative
alkalinization of the extracellular fluid due to insulin treatment
would further promote Na/H exchange, favoring sodium and
water influx into brain. Insulin, which activates Na/H exchange
in other tissues [14, 15], and hyperglycemia, which may cause
osmotic disruption of the blood brain barrier [16], have also been
proposed as pathogenic factors. These mechanisms would result
in an influx of sodium and water into the brain.
An alternative suggestion is that the brain accumulates osmot-
ically active solutes in DKA in an adaptive response to severe
hyperglycemia. The proposed response would preserve cell vol-
ume but cause water flow into the brain as plasma osmolality is
rapidly decreased during treatment. In this case, an adaptive efflux
of sodium from brain would be expected.
Several experimental studies have attempted to define the
pathogenic mechanism of cerebral edema after treatment of
DKA. In hyperglycemic dogs, Prokop identified an increase in
cerebrospinal fluid sorbitol and fructose content. He postulated
that an increase in these solutes in brain resulted in brain edema
when blood sugar was rapidly lowered [17]. Arieff and colleagues,
in a series of studies in the early 1970s, induced severe hypergly-
cemia by glucose infusion in both normal and diabetic rabbits [18,
19]. They observed that two hours of hyperglycemia resulted in
brain dehydration, but after four hours brain water had returned
to normal values and measured brain osmolytes only partially
accounted for an increase in total brain tissue osmolality as
measured by freezing point osmometry. An increase in brain
sorbitol or other measured osmolytes was not confirmed, and
formation of "idiogenic osmoles" to preserve cell volume was
proposed. Rapid correction of hyperglycemia with insulin caused
sodium and chloride influx into the brain, a further increase in
idiogenic osmoles, and cerebral edema. Lowering of glucose
without insulin (by peritoneal dialysis) prevented the increase in
brain sodium and water. Thus, it was suggested that insulin played
a primary role in the pathogenesis of brain swelling by increasing
brain sodium content and stimulating formation of unidentified
solute. However, acidosis and plasma sodium were not controlled
for in these studies.
Recently, it has been proposed that idiogenic osmoles involved
in cell volume regulation are, in fact, organic osmolytes consisting
primarily of amino acids, trimethylamines, and polyols [20, 21].
Study of changes in these brain osmolytes in diabetic ketoacidosis
and its treatment has been limited. Harris et al found that taurine
was increased in experimental DKA in rats, implying that this
osmolyte also contributed to cell volume regulation in severe
1237
1238 Silver et al: Cerebral edema after treatment of DKA
diabetes [22]. Trachtman, Futterweit and Sturman found an
increase in cerebral synaptosomal taurine transport in diabetic
rats [231, and Bedford and Leader described increases in rat brain
content of taurine, glutamate, and glutamine after five days of
hyperglycemia [24]. It has also been suggested that myoinositol
accumulation might contribute to the cerebral edema after treat-
ment of diabetes [25].
The current studies examine the roles of acidosis, plasma
osmolality, and brain organic osmolytes in the pathogenesis of
cerebral edema after treatment of DKA. We compare brain water
and solute content in rat models of nonketotic and ketotic
diabetes mellitus, and address the effect of hypotonic fluid admin-
istration during treatment of diabetic ketoacidosis on the devel-
opment of cerebral edema.
Methods
For all studies, male Sprague-Dawley rats (Holtzman, India-
napolis, IN, USA) weighing 300 to 350 g were used. Rats were
housed in 12-hour light-dark cycles and given free access to
regular laboratory chow.
Experiment I: Treatment of non-ketotic versus ketotic diabetes
Rat model of untreated and treated nonketotic diabetes mellitus
(NKD). Rats were divided into three experimental groups: Non-
diabetic Controls, Untreated NKD, and Treated NKD. NKDwas
produced by injection of streptozocin (Upjohn, Kalamazoo, MI,
USA) 65 mg/kg via superficial femoral vein under methohexital
anesthesia (50 mg/kg i.p.). Nondiabetic control rats were similarly
anesthetized and injected with citrate buffer intravenously. After
recovery from anesthesia, all streptozocin injected rats were given
D10 as drinking water for 24 hours following injection and tap
water thereafter. Serial urine dipsticks (Ketosticks) were per-
formed to ensure the absence of ketonuria in all rats. No
maintenance insulin was administered following injection with
streptozocin. Six days after the injection, all rats were anesthetized
with ketamine (40 mg/kg i.p.) and PE-50 tubing was placed in the
femoral vein and artery. Following line placement and initial
blood sampling, Nondiabetic Control and Untreated NKD rats
were sacrificed by decapitation and brain tissue was analyzed as
described below.
Pretreatment blood samples were obtained from the treated
NKD group, followed by a 60-minute intravenous infusion of
regular insulin and hypotonic electrolyte solution. Intravenous
fluid consisted of 42 mi NaCI, 30 mvi NaHCO3, and 5 mrvi KCI
given as an initial bolus of 7.5 ml/100 g body wt over 15 minutes,
followed by the continuous infusion of 2.5 mi/I 00 g body wt over
the remaining 45 minutes of the 60-minute treatment period.
Regular insulin was given as an initial bolus of 1.0 unit, followed
by the continuous infusion in the intravenous fluid of 0.5 units
over 15 minutes, and another 0.5 units/mI intravenous fluid over
the remaining 45 minutes of the treatment period. Electrolyte
content of the infusate was chosen to maintain a constant plasma
sodium over the course of the treatment protocol. Sixty minutes
after completing the treatment infusion and 120 minutes after
beginning treatment, final blood sampling was performed and rats
were sacrificed by decapitation.
Rat model of untreated and treated ketotic diabetes mellitus
(DKA). Three groups of rats were studied: Nondiabetic Controls,
Untreated DKA, and Treated DKA. The animals were anesthe-
tized with methohexital as above and injected intravenously with
streptozotocin 150 mg/kg. Nondiabetic Controls were injected
with citrate buffer. After recovery from anesthesia all streptozocin
injected rats were given D10 as drinking water for 24 hours, then
switched to tap water. On days 2 through 5, a once-daily injection
of Ultralente insulin 2 units was given subcutaneously to all DKA
rats. This dose of insulin resulted in significant ketoacidosis with
hyperglycemia. On day 6, rats were anesthetized with ketamine 40
mg/kg i.p. and arterial and venous lines were placed as in the NKD
study. Following line placement and initial blood sampling, Non-
diabetic Controls and Untreated NKD rats were sacrificed by
decapitation and brain tissue was analyzed as described below.
Pretreatment blood samples were obtained from the treated
DKA group, followed by a 60-minute intravenous infusion of
regular insulin and hypotonic electrolyte solution. Intravenous
fluid consisted of 75 mrvi NaHCO3, and 25 mrvi KC1 given as an
initial bolus of 7.5 ml/100 g body wt over 15 minutes, followed by
the continuous infusion of 3.5 ml/100 g body wt over the remain-
ing 45 minutes of the 60-minute treatment period. Regular insulin
was given as an initial bolus of 1.0 unit, followed by the continuous
infusion in the intravenous fluid of 0.5 units over 15 minutes, and
another 0.375 units/mi intravenous fluid over the remaining 45
minutes of the treatment period. Electrolyte content and rate of
the infusate was chosen to maintain a constant plasma sodium
over the course of the treatment protocol, and to correct meta-
bolic acidosis. Sixty minutes after completing the treatment
infusion and 120 minutes after beginning treatment, final blood
sampling was performed and rats were sacrificed by decapitation.
Experiment 11: Treatment of DKA with hypotonic versus isotonic
fluid
This experiment examined the role of the osmoiaiity of intra-
venous fluid used in treatment on the development of cerebral
edema in DKA. DKA was induced as described in experiment I.
Six days after injection with streptozotocin, two groups of DKA
rats were studied. In one group, DKA was treated identically to
that described in the DKA protocol in experiment I; in the second
group, insulin treatment and the volume of infusate were identical
to experiment I, but the electrolyte content was adjusted to be
isotonic (75 mM NaHCO3, 54 mrvi NaC1, and 25 mivt KC1). Sixty
minutes after completing the treatment infusion and 120 minutes
after beginning treatment, rats were sacrificed by decapitation.
Analytical procedures
Plasma electrolytes, urea nitrogen, creatinine, glucose, total
C02, and plasma osmolality were measured with a Synchron CX3
Clinical System (Beckman Instruments, Fullerton, CA, USA) and
arterial blood gases with a Radiometer ABL 330 blood gas
analyzer (Copenhagen, Sweden). Plasma /3-hydroxybutyrate was
measured with a -hydroxybutyrate dehydrogenase enzymatic
assay (Sigma, St. Louis, MO, USA).
Immediately after decapitation, rat skulls were bisected sagit-
tally with an electric scroll saw. One hemisphere was quickly
removed, placed in liquid nitrogen within 15 seconds, and stored
at —70°C until analyzed for organic osmolyte content. The
remaining hemisphere was removed and utilized for determina-
tion of water and electrolyte content. Freezing of brain in situ,
required for accurate measurement of brain glucose, was not
performed because this method would preclude precise measure-
ment of brain water. Water content was determined by obtaining
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Table 1. Plasma values and body weight in non-ketotic diabetic (NKD) and ketotic diabetic (DKA) rats
ControlN=9
NKD
untreated
N=10
NKD
pre-treatmentN=9
NKD
post-treatmentN=9 ControlN=9
DKA
untreated
N=11
DKA
pre-treatmentN=11
DKA
post-treatmentN=11
Urea miw 5.2 0.4 9.5 0.7" 9.0 0.4" 9.7 0.6" 6.2 0.4 13.2 1.4"" 14.9 2.6a 11.8 2.3
Glucose mM 9.9 0.5 43.7 2.2a 41.6 2.9a 6.4 0.6" 9.6 0.4 31.3 08ab 32.1 isa 6.2 05ad
Osmolality mOsm/kg 305 3 345 6" 352 2° 309 5" 301 3b 338 331 3ab 291 35d
Sodium mM 142 1 137 ia 137 2 140 1 143 1 139 ia 139 1 138 ia
Potassium mM 5.0 0.2 4.8 0.2 4.8 0.3 4.0 0.3" 4.4 0.2 3.6 0.2"" 3.1 01ab 2.8 0.1""
Total CO2 mM 24 1 22 1 22 1 23 2 26 1b 1ab 10 1ab 20 1ad
Chloride m 106 1 97 1" 97 2" 104 2' 106 2 112 2" 110 2b 106 1d
13-OH-Butyrate m ND ND ND ND ND 3.7 8th 3.6 6" 0.6 0.2"
pH 7.44 0.01 7.40 0.02 7.37 0.02 7.49 .03" 7.40 0.01 7.08 005ab 7.07 0.03"" 7.39 0.02"
PA CO2mm Hg 39±1 41±1 45±2 33±2 40±2 352b 362b 34±2
POO2mmHg 89±2 85±3 81±8 87±4 983" 117÷7"" 113±4" 109±5"
Body weight g 315 9 275 9° 270 4" 294 5 327 5 259 6"" 247 6" 270 6"
P < 0.05 versus control group
'P < 0.05 versus respective NKD group
P < 0.05 versus NKD pretreatment group
"P < 0.05 versus DKA pretreatment group
an initial wet wt, then oven drying the brain tissue at 100°C for 48
hours, after which time it was re-weighed. Dried brain was then
extracted for 48 hours in 0.75 N HNO3 and sodium and potassium
content determined by flame photometry (Model No. 943; Instru-
mentation Laboratories, Lexington, MA, USA). Chloride content
was measured with a chloride ion-selective electrode (Corning
Instruments, Corning, NY, USA).
The method for measurement of organic osmolyte content in
brain has been described previously [26]. Frozen brain tissue was
crushed under liquid nitrogen and lyophilized. Amino acid con-
tent of lyophilized brain tissue was then determined by high
performance liquid chromatography after derivitization with phe-
nylisothiocyanate (Pico Tag; Waters Corporation, Milford, MA,
USA). Methionine sulfone served as the internal standard. The
content of myoinositol, sorbitol, creatine and betaine was deter-
mined by HPLC utilizing a Sugar Pak II Column (Waters).
Maltose was utilized as the internal standard for each sample.
Statistical analysis
Data are presented as mean values SE. Studies comparing
groups within an experimental model (DKA or NKD) were
assessed by one-factor analysis of variance with significance
determined by the Scheffe F-test (Statview 512k Brain Power,
Calabasas, CA, USA). Comparison of two groups in different
experimental models (DKA vs. NKD, or hypotonic vs. isotonic
fluid) was performed by use of an unpaired Student's t-test.
Significance was accepted at the P < 0.05 level.
Results
Experiment I: Treatment of non-ketotic versus ketotic diabetes
In Table 1, body wt and plasma chemistry data are given for
nondiabetic control, untreated diabetic and treated diabetic
groups for both non-ketotic and ketotic diabetic models. In the
NKD model, significant hyperglycemia and volume depletion
occurred in the absence of ketoacidosis. In untreated and pre-
treatment NKD rats plasma glucose was 43.7 2.2 and 41.6 2.9
m respectively. In DKA rats severe hyperglycemia and ketoaci-
dosis developed, though plasma glucose levels in untreated and
pre-treatment animals (31.1 0.8 and 32.1 1.5 mM) were
significantly less than in NKD. This was associated with a signif-
icantly lower measured plasma osmolality prior to treatment in
DKA than NKD.
In response to treatment with intravenous fluids and insulin,
plasma glucose concentration decreased rapidly over the 60-
minute treatment period and remained stable for 60 minutes
following treatment (Fig. 1). Although plasma glucose values were
higher in NKD than DKA rats prior to treatment, they fell to
equivalent levels with treatment. There was no difference in the
fall in plasma osmolality between models with a reduction of 42
2 mOsm/kg in NKD rats versus 40 3 mOsm/kg in DKA rats.
Calculating the decrease in plasma tonicity using only sodium and
glucose values also did not reveal a significant difference between
groups. There was no significant change in plasma sodium follow-
ing treatment in either NKD or DKA models and pre- and
post-treatment plasma sodium levels were equivalent. In the DKA
I Treatment period
w(I)00
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0 30 60 90 120
Time after initiation of treatment, minutes
Fig. 1. Course of plasma glucose with treatment of NKD (LI) and DKA (+)
rats. *p < 0.05 versus DKA.
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Table 2. Brain content of water and inorganic solutes in NKD and DKA rats
NKD DKA
Control Untreated Treated Control Untreated Treated
N=9 N=10 N=9 N=9 N=11 N=11
Brain water liter/kg d wt
Brain sodium mmol/kD' thy wt
3.73 0.03
192 1
3.65 0.02
192 2
3.90 002th
182 2' 3.75 0.01195 1
3.64 0.02
201 2
393 0.02
187 2"
Brain potassium mmol/kg thy wt 446 2 446 2 443 4 464 2 468 3 472 5
Brain chloride rnmol/kg diywt 187 7 175 4 160 4' 188 6 200 10 184 8
-
P < 0.05 vs. control
"P < 0.05 vs. untreated group
ci>
(I)
a)
cci
C
cci
4
3
2
rats, treatment reduced p-hydroxybutyrate concentration sig-
nificantly. Metabolic acidosis also resolved with treatment in
DKA rats and significant hypoxemia was not present in any
group.
Brain water contents in nondiabetic control, untreated and
treated diabetic groups for both NKD and DKA models are given
in Figure 2. The decrease in brain water from 3.73 0.03 liter/kg
dry weight in controls to 3.65 0.02 liter/kg dry weight in
untreated NKD did not reach statistical significance. However,
with treatment, brain water increased significantly to 3.90 0.02
liter/kg dry weight. A similar pattern was found in DKA. Brain
water content in untreated DKA was significantly less than that in
nondiabetic control animals (3.64 0.02 vs. 3.75 0.01 liter/kg
dry weight, P < 0.05). As in NKD, brain water content in DKA
rats increased significantly with treatment to 3.93 0.02 liter/kg
dry weight. When comparing brain water content between NKD
and DKA rats, there were no differences between nondiabetic
control, untreated or treated groups (Fig. 2).
In both NKD and DKA models, brain sodium content fell
following treatment, and brain chloride fell in NKD (Table 2 and
Fig. 3). There were no significant changes in brain potassium
content. Increases in brain organic osmolyte content were also not
identified in uncontrolled NKD or DKA (Tables 3 and 4). After
treatment, brain glutamine and taurine content increased signifi-
cantly in DKA, but brain content of the summed total of major
Fig. 3. Contribution of organic and inorganic osmolytes to total brain
osmolytes control (C), untreated (No Tx) and treated (Tx) groups in both
NKD and DK4. Symbols are: () organic osmolytes; (ti) chloride; (U)
potassium; (U) sodium.
organic osmolytes was not significantly increased (Table 3 and Fig.
3).
Experiment II. Treatment of DKA with hypotonic versus isotonic
fluid
To further explore the contribution of osmotic shifts to the
development of cerebral edema in diabetic ketoacidosis, we
compared brain water and electrolyte content in DKA rats treated
with hypotonic versus isotonic replacement fluid. In Table 5,
plasma values and body wt for these two groups are given. As in
experiment I, severe hyperglycemia and metabolic acidosis was
produced in both groups. The plasma glucose of 38.1 2.1 mM
and pH of 7.02 0.04 in the isotonically-treated group did not
differ from the plasma glucose of 37.8 4.1 mM and pH of 7.07
0.05 in the hypotonically-treated group. Normal arterial oxygen-
ation was present in both groups throughout the study. In
response to treatment, blood glucose values decreased at similar
rates, reaching nearly identical values at 60 and 120 minutes (Fig.
4). Metabolic acidosis was also equivalently reversed in both
groups. Plasma sodium concentration increased in the isotonic-
treated group, but remained at pretreatment level in the hypo-
tonic fluid-treated group. Correspondingly, plasma osmolality
decreased less during treatment in the isotonic group than in the
hypotonic group (55 5 mOsm/kg vs. 71 6 mOsm/kg, P <
0.05). Post-treatment brain water and electrolyte contents of
NKD DKA
Fig. 2. Comparison of brain water contents in NKD and DKA groups (*P <
0.05 vs. other groups, P < 0.05 vs. non-diabetic control). There was no
significant difference between respective control (LII), untreated (U), and
treated () NKD and DKA groups.
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Table 3. Brain content of major organic osmolytes measured in NKD and DKA rats (expressed in mM/kg dry brain tissue wt)
NKD DKA
Control Untreated Treated Control Untreated TreatedN=9 N=10 N=9 N=9 N=11 N=11
Myoinositol
Taurine
18.0 1.6
21.8 1.4
18.9 1.3
26.0 1.5
17.2 2.0
23.1 2.0
23.9 0.8
21.3 1.5
24.1 0.7
24.6 2.0
23.6 0.5
28.9 2.2a
Glutamate 51.6 3.1 54.7 3.2 48.7 3.4 46.4 3.7 46.9 3.3 53.3 3.1
Glutamine 23.3 1.3 26.4 1.8 26.8 2.5 23.2 1.7 23.0 1.8 32.1 22ab
Creatine 37.3 3.7 39.6 1.6 37.0 4.1 34.9 1.8 33.7 0.8 34.9 1.0
Total major organic
osmolytes
152 11.0 165 4.5 152 8.9 150 6.6 152 7.6 174 8.4
P < 0.05 vs. control group
bP < 0.05 vs. untreated group
Table 4. Brain content of urea, glucose, and minor organic osmolytes measured in NKD and DKA rats (expressed in mM/kg dry brain tissue wt)
NKD DKA
Control Untreated Treated Control Untreated Treated
N=9 N=10 N=9 N=9 N=11 N=11
Urea 12.4 0.9 18.9 1.4a 17.7 2.8 13.3 0.9 22.9 2.Oa 16.9 2.1
Sorbitol 5.10 0.6 6.29 0.6 4.81 0.8 5.09 0.5 5.21 0.3 3.58 0.3'
Glycine 3.52 0.2 3.60 0.2 3.50 0.2 3.30 0.3 3.73 0.2 3.73 0.3
Betaine 2.07 0.2 1.95 0.1 1.96 0.2 1.05 0.1' 1.17 0.1 0.99 Ole
y-Aniinobutyric acid 9.25 0.65 9.38 0.55 8.41 0.62 6.67 0.50' 6.62 0.46e 7.92 0.48
Phosphoserine 8.45 0.42 9.25 0.78 6.69 0.5l' 8.68 1.2 9.09 0.80
Phosphoethanolamine 6.27 0.35 6.37 0.30 4.91 0.52" 5.33 0.38 5.36 0.30
7.07 0.76
5.79 0.56
Serine 5.41 0.37 4.88 0.28 4.75 0.37 4.78 0.45 4.23 0.28 4.91 0.39
Alanine 4.42 0.53 6.30 0.81 5.41 0.98 2.16 0.21C 2.40 0.21" 2.63 0.21"
cx-Aminobutyric acid 3.36 0.33 3.51 0.19 2.65 0.33 2.93 0.30 2.57 0.24C 3.34 0.43
Aspartic acid 2.44 0.37 2.12 0.29 1.97 0.23 6.60 0.81" 6.81 0.45" 5.55 0.76"
Threonine 2.26 0.15 1.67 0.1OC 1.63 0.19a 2.16 0.21" 2.40 0.21" 2.63 0.21"
Other osmolytes" 3.45 0.33 3.67 0.33 3.63 0.36 3.03 0.24 3.05 0.20 3.48 0.34
"P < 0.05 vs. control group
h P < 0.05 vs. untreated group
P < 0.05 vs. respective NKD group
dSum of ethanolamine, valine, methionine, cystathione, isoleucine, leucine, arginine, tyrosine, 13-alanine, and asparagine
Table 5. Plasma values and body weight in DKA rats treated with isotonic or hypotonic fluid repletion
Hypotonic Isotonic
pre-treatment post-treatment pre-treatment post-treatmentN=9 N=9 N=9 N=9
Urea mM 19.2 2.9 15.7 1.7 23.1 2.4 16.1 1.7
Glucose m,u 39.5 5.1 6.7 0.61" 38.1 2.0 6.0 0.6"
Osmolality mOsm/kg 372 10 301 3" 368 8
Sodium mM 142 1.5 141 1.3 141 1.1
312 3""
148 0.8"
Potassium mu 3.4 0.2 2.8 0.1 3.5 0.1 3.5 0.2"
Total CO2 mi 9 1 20 0.1" 11 2 21 2"
Chloride m 110 1.0 105 2 114 1.2 119 1"
pH 7.07 0.04 7.42 0.02" 7.02 0.04 7.36 0.01"
PA CO2 mm Hg 38.4 3.3 30.5 2.4 36.5 2.4 34.3 1.7
PAO2mmHg 115±8 107±3 121±7 115±7
Weight g 237 5 264 5 6 252 6"
"P < 0.05 versus pretreatment
P < 0.05 versus hypotonic post-treatment
isotonic and hypotonic groups are shown in Table 6. Significantly Discussion
less brain swelling occurred in animals treated with isotonic
solution. Despite increased brain water, brain sodium content in In the current study, we established an animal model of severe
rats treated with hypotonic fluid was significantly lower than those non-ketotic and ketotic diabetes mellitus in order to more clearly
treated with isotonic fluid. There was no difference in brain define the pathogenesis of cerebral edema that occurs after
potassium content between the two treatment groups. treatment of severe diabetes. The model controlled for the
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presence or absence of acidosis so that its contribution to brain
swelling could be assessed. Plasma sodium was maintained within
normal limits after treatment of diabetes so that changes in brain
water could be assessed independent of changes in plasma
sodium. In our model, severe diabetes was present for five days
prior to treatment, allowing adequate time for brain adaptation to
the osmotic milieu. In contrast to previous studies, acute infusion
of hypertonic glucose was not superimposed [18, 19]. Plasma
values prior to treatment approximated human non-ketotic and
ketotic diabetes. However, in animals with DKA, the increased
anion gap and beta hydroxybutyrate concentration did not fully
account for the decrease in plasma bicarbonate. Increased urinary
losses of ketone bodies and a fall in plasma albumin, neither of
which were measured in the study, may have contributed to this
finding. Plasma osmolality and acidosis were corrected more
rapidly (over two hours) than under normal clinical conditions in
order to accentuate any differences between experimental groups.
The study included measurement of brain organic osmolytes
known to be involved in the adaptive response to osmotic
perturbations [20, 211.
Rapid correction of hyperglycemia (Fig. 1) and hyperosmolality
resulted in a significant increase in brain water content (Fig. 2). In
both NKD and DKA, plasma osmolality decreased by about 12%
with treatment. If the brain were a perfect osmometer and no
solute were lost during treatment, an equivalent increase in brain
water would be expected. However, the actual observed increase
in brain water after treatment of NKD and DKA was only about
8%. Loss of brain electrolytes only partially accounts for the
discrepancy between observed and predicted values. We assumed
that during correction of hyperglycemia, glucose was also lost
from brain; however, as discussed earlier, our experiments were
not designed to measure these changes. Studies by other investi-
gators, in which glucose was measured in tissue that had been
frozen in situ, show that brain glucose concentration is about 30%
of plasma values both before and after treatment of hyperglyce-
mia [271. If we assume that brain glucose content was similar in
our studies, we would expect that brain glucose content would
have decreased by approximately 25 to 35 mM/kg dry tissue
Hypotonic Isotonic
Brain water (L/kg dry wt) 3.90 0.02 3.78 0.02a
Brain sodium (mmol/kg dry wt) 206 3.3 215 l.3'
Brain potassium_(mmollkg dry wt) 484 2.7 486 2.2
weight, an amount that exceeds the measured loss of electrolytes.
If brain glucose and electrolyte solute losses are taken into
consideration, the calculated and actual increase in brain water
after treatment of NKD and DKA are similar (Appendix). Thus,
brain swelling after treatment of diabetes could be explained
without invoking new solute formation ("idiogenic osmoles").
Consistent with these observations, we found no significant in-
crease in total brain organic osmolytes after treatment of non-
ketotic or ketotic diabetes. However, because of the limited
sensitivity of our methodology, we cannot exclude small increases
in total organic osmolytes that would be difficult to detect. Indeed,
after treatment of DKA, total brain organic osmolytes did trend
upward and the individual osmolytes taurine and glutamine
increased. However, the total osmotic contribution of these
changes has little impact on our conclusions.
Brain sodium decreased equivalently in both non-ketotic and
ketotic groups after treatment. Rather than causing brain edema,
changes in brain sodium served to militate against it. A similar
decrease in brain sodium occurs when brain swelling is induced
with hyponatremia. This adaptation is thought to be due to loss of
sodium chloride from the brain via bulk flow of interstitial fluid
into the cerebrospinal fluid [28]. Our findings differ from those of
Arieff, who found that brain sodium increases in animals that
develop cerebral edema after treatment of severe hyperglycemia
[18, 19]. It has been hypothesized that stimulation of Na*/H±
exchange (via insulin or correction of acidosis) or increased
blood-brain barrier permeability to sodium induced by hypergly-
cemia may predispose to cerebral edema [13]. If this were the
primary event, brain swelling would be expected to be associated
with an increase in brain sodium. In contrast, our findings imply
that the primary pathogenic mechanism for brain swelling was not
driven by sodium influx into brain. Presumably, it was driven by
influx of water to brain cells that had retained additional solute
while adapting to hyperglycemia.
The present studies compared animals with diabetic ketoacido-
sis treated with hypotonic and isotonic fluid in an attempt to more
directly assess the contribution of osmotic change to the patho-
genesis of the cerebral edema observed. Brain water in animals
treated with isotonic fluid (Table 6) was similar to non-diabetic
controls and higher than in untreated DKA (Table 2), suggesting
that a limited increase in brain water did occur with its use.
However, treatment with hypotonic fluid decreased plasma so-
dium and osmolality to a greater degree and resulted in signifi-
cantly more brain swelling than in animals treated with isotonic
fluid, despite lower brain sodium content. The differences in
plasma osmolalities in the two groups can account for the
differences in brain water. Assuming equality of brain and plasma
osmolality, total brain solute after treatment in the hypotonic
group would equal plasma osmolality >< brain water content (301
mOsm/kg >< 3.90 liter/kg brain tissue = 1174 milliosmoles); in the
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Tabk 6. Brain content of water and inorganic solutes in ketotic
diabetic animals treated with hypotonic or isotonic fluid repletion
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Fig. 4. Course of plasma glucose in DKArats treated with hypotonic (LI) or
isotonic (•) fluid.
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isotonic group, total brain solute is similar to the hypotonic group
(312 mOsm/kg X 3.78 liter/kg brain tissue = 1179 milliosmoles).
The result confirms the predominant effect of a rapid decrease in
plasma osmolality in the pathogenesis of the cerebral edema
observed in our experiments: since isotonic fluid minimized brain
swelling despite use of insulin, correction of acidosis, and presum-
ably similar lowering of oncotic pressure in both groups, these
factors do not appear to have played a major role in the brain
swelling observed. Moreover, brain sodium content in the hypo-
tonic group was significantly lower than in the isotonic group,
indicating that the cerebral edema was not due to sodium influx
into brain. Rather, sodium efflux from brain occurred, presumably
as an adaptive response to cerebral edema.
It may seem surprising that brain water did not rise above
normal levels when ketoacidosis was treated with isotonic fluid
even though the increase in plasma osmolality due to an increase
in plasma sodium (approximately 14 m compared to hypotonic
fluid therapy) failed to match the decrease in plasma osmolality
due to a falling blood sugar (approximately 30 mM). However, it
should be noted that after treatment with both hypotonic and
isotonic fluid, brain water increased in comparison to untreated
diabetes.
Our findings do imply that the routine use of hypotonic fluid
replacement in DKA after obtaining hemodynamic stability with
isotonic fluid be reconsidered. Currently, the general goal of such
treatment is to maintain serum sodium at pretreatment levels
while decreasing plasma osmolality by correction of hyperglyce-
mia. Clearly, the results of the present study cannot be extrapo-
lated to the clinical arena. However, treatment regimens that
allow the serum sodium level to increase initially, to offset the
osmotic effect of the decrease in blood glucose, may be desirable.
Cerebral edema was equivalent after treatment of both non-
ketotic and ketotic diabetic animals, indicating that the presence
and correction of severe diabetic ketoacidosis in the present
experiments were not major factors predisposing to brain swelling
(Fig. 2). However, the experimental findings do not completely
exclude a contribution of acidosis or its correction to the increase
in brain water. Pretreatment plasma glucose was about 10 m less
in acidotic versus non-acidotic animals, and thus more brain
swelling in acidotic animals might have been observed if pretreat-
ment plasma glucose had been equivalent between groups. How-
ever, both the plasma osmolality and plasma tonicity (calculated
contribution of sodium and glucose to osmolality) decreased to
the same degree after treatment in non-ketotic and ketotic
groups. The brain content of taurine and glutamine increased
after treatment of ketotic diabetes, though the increase in total
major brain organic osmolytes was not significant. Nonetheless,
the differences in brain organic osmolyte content after treatment
of non-ketotic and ketotic diabetes deserve further investigation.
Our studies do not explain the apparent predisposition to cerebral
edema in DKA in the clinical setting. Possibly, younger patients,
who have a higher incidence of DKA than adults, are more
susceptible to brain swelling.
Although our studies could account for the increase in brain
water that occurs after treatment of diabetes, we could not
account for the brain's resistance to dehydration in untreated
diabetes. In the present study, plasma osmolality of untreated
diabetic animals increased by approximately 12%, due to hyper-
glycemia. If we assume, as discussed previously, that brain glucose
concentration is 30% that of plasma, a 12% increase in plasma
osmolality due to hyperglycemia would be associated with a 4%
increase in brain glucose concentration. Thus, if the brain were a
passive osmometer, an 8% decrease in brain water would be
expected. In fact, however, brain water in non-ketotic and ketotic
diabetes was only 2% lower than controls, and this difference
reached statistical significance only in the ketotic group. The
present study cannot explain this observed adaptation to the
hyperosmolality on the basis of an increase in brain solute. In our
study, in contrast with other investigators, no significant change in
brain electrolyte or organic osmolyte content was found in either
non-ketotic or ketotic diabetes [22, 24]. Thus, our results indicate
that the organic osmolytes which function to preserve brain water
in hypernatremia do not serve this role in hyperglycemia. We
cannot exclude an increase in other unidentified osmolytes, or an
increase in the osmotic activity of known osmolytes.
In summary, treatment of both non-ketotic and ketotic animals
resulted in a nearly equivalent degree of cerebral edema with no
change in total measured osmolytes (although brain glutamine
and taurine increased after treatment of ketotic animals). Cere-
bral edema could be attributed to the decrease in plasma osmo-
lality during correction of hyperglycemia, and the presence of
acidosis appeared to play a minor role. Despite the cerebral
edema induced in our studies, brain sodium decreased, demon-
strating that the brain swelling was not due to a process resulting
in sodium influx into the brain. Treatment of ketotic hyperglyce-
mic animals with isotonic saline conferred significant protection
against cerebral edema, confirming the dominant influence of
changes in plasma osmolality.
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Appendix: Predicted brain water in treated NKD and DKA
Assuming that the brain and plasma are in osmotic equilibrium, the
change in brain water (BW) can be predicted by the measured change in
plasma osmolality (P0,,,) and brain solute (B50) before and after (pre and
post) treatment of diabetes using the following relationship:
and thus,
Pt,m (pre)
—
B501 (pre)/BW (pre)
P, (post) B501 (post)IBW (post)
BW (post)
—
Pm (pre) Ba,i (post)
BW (pre) P,,, (post) B (pre)
At osmotic equilibrium, brain solute content equals the product of
plasma osmolality and brain water content. If brain electrolytes were the
only solutes to change during treatment of diabetes, then
B501(post) = [Po,m(pre) X BW (pre)] + (zbrain electrolyte content)
Thus,
BW (post)
—
[Posm (pre) X BW (pre)] + (z brain electrolyte content)
BW (pre) Pm (post) X BW (pre)
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A predicted value for post-treatment brain water can be calculated from
the pretreatment and post-treatment plasma osmolality values and the
measured pretreatment and posttreatment brain electrolyte content. This
calculation provides the change in brain water that would be predicted if
only brain electrolytes were to change during treatment. Based on the
above assumptions, the actual and predicted increase in brain water for
NKD (7.2 1.2% vs. 9.7 1.3%, P = NS) and DKA (8.0 0.5% vs.
11.4 1.0%, P < 0.05) indicate that the changes in plasma osmolality and
brain electrolytes alone are more than enough to account for the
measured brain water changes.
The above estimation, however, assumes no change in brain glucose
with treatment. Because an accurate determination of brain glucose
requires in situ freezing of brain tissue, (a method that would have
sacrificed precision in our measurement of brain water) this analysis was
not made in the present studies. Based on studies of other investigators in
which brain glucose was determined in diabetic rats after in situ freezing
of brain tissue, brain glucose concentration can be assumed to equal 30%
of the plasma value [27]. Using this assumption, a prediction of brain
water based on changes in brain electrolyte and glucose content can be
calculated from the following equation:
BW (post)
BW (pre)
[POsm (pre) >< BW (pre)] + ( brain electrolyte content +
brain glucose content)
POsm (post) X BW (pre)
Based on changes in both brain glucose and electrolytes, there is less
difference between the actual and predicted increase in brain water for
NKD (7.2 1.2% vs. 7.5 1.3%, NS) and DKA (8.0 0.5% vs. 8.5
2.6%, NS) than if only brain electrolytes were assumed to have changed.
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